Dimensions Plus provides access to Dimensions’ complete, comprehensive, and connected data set covering publications, grants, patents, clinical trials, datasets and policy documents. The features and functionalities have been developed in close collaboration with the research community to meet the full range of your institution’s discovery and search needs.
Search across all content types
Dimensions Plus offers access to more than 100 million publications, ranging from articles published in scholarly journals, books and book chapters, to preprints and conference proceedings. But there’s more: Dimensions Plus is an extensive and fully interlinked database with publications, grants, patents, clinical trials, datasets and policy documents. Within Dimensions Plus, you can simultaneously search across all content types and apply filters to get a 360° view on research activity.
Enhanced discovery tools
Dimensions Plus aggregates data across all content types to deliver a full picture of past, current, and future research. Article-level research categories are consistently applied to all content types, as well as funder and research organizations. In comparison to the free version, Dimensions Plus offers greater export limits for standard xlsx/csv exports and bibliometric mapping with VOSviewer and CiteSpace. You can also view Altmetric online attention for individual items, or aggregate the data for both publications and clinical trials.
Full text access
With Dimensions, you can access the full-text PDF versions of more than 30 million Open Access articles with just one click.
We support several authentication options: IP whitelisting, EZproxy and Single-Sign-On (Shibboleth etc.). This ensures your institution’s researchers can view Dimensions data at any time and from any location.
We are here to help, whenever you need us – our team offers a 24/7 support service. To help you get the most out of Dimensions’ rich data, we also offer a range of information materials, host regular webinars, and invite you to send in your questions.